Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Dienogest and Ethinyl Estradiol 2.0 mg/0.03 mg Tablets
NCT04193852Phase 1Completed
- Sponsor
- Laboratorios Andromaco S.A.
- Start
- Nov 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dienogest and ethinyl estradiol in contraception (2 arms), sponsored by Laboratorios Andromaco S.A. Primary endpoints: Area under the plasma concentration-time curve from 0 to 72 hours, Area under the plasma concentration-time curve from 0 to time t and 2 more. Started Nov 2019; status: completed.
02
Drugs
dienogestethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT04193852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04193852.